close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MiNK Therapeutics, Inc. - Common Stock (NQ:INKT)

9.790 -0.430 (-4.21%)
Delayed Quote Updated: 2:40 PM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about MiNK Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
MiNK Therapeutics (INKT) Q3 2026 Earnings Call Transcript ↗
First revenue lands as the ARDS trial enters randomized Phase II. 
Via The Motley Fool
Topics Earnings
News headline image
What MiNK Therapeutics (INKT) Said on Its Q3 Earnings Call ↗
MiNK Therapeutics (NASDAQ:INKT) has initiated a randomized Phase 2 trial of its investigational cell therapy agenT-797 in patients with severe acute lung injury and respiratory distress, with... 
Via MarketBeat
Topics Earnings
News headline image
MiNK Therapeutics (INKT) Q2 2026 Earnings Call Transcript ↗
Net loss narrowed to $3.1 million as Phase 2 trial for agenT-797 advances in Ukraine. 
Via The Motley Fool
Topics Earnings
MiNK Therapeutics (NASDAQ:INKT) Posts Narrower-Than-Expected Q1 Loss, Advances iNKT Therapy Into Pivotal Testing ↗
Via Chartmill
News headline image
Earnings Scheduled For August 14, 2025 ↗
 
Via Benzinga
News headline image
MiNK Therapeutics Q2 Earnings Call Highlights ↗
MiNK Therapeutics (NASDAQ:INKT) said it initiated dosing in a randomized Phase II trial of its allogeneic invariant natural killer T-cell therapy, agenT-797, for patients with acute lung injury and... 
Via MarketBeat
Topics Earnings
News headline image
MiNK (INKT) Q4 2025 Earnings Call Transcript ↗
MiNK (INKT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
MiNK (INKT) Q1 2026 Earnings Call Transcript ↗
MiNK (INKT) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
MiNK Therapeutics Q1 Earnings Call Highlights ↗
MiNK Therapeutics (NASDAQ:INKT) said it is advancing its off-the-shelf invariant natural killer T cell therapy platform into a randomized clinical program for severe acute lung injury and acute... 
Via MarketBeat
Topics Earnings
These stocks are gapping in today's session ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
News headline image
Why Did INKT Stock Surge 70% In Pre-Market Today? ↗
MiNK Therapeutics tied up with an oncology consortium to develop a cell therapy targeting pediatric cancers. 
Via Stocktwits
News headline image
MiNK Therapeutics (INKT) Earnings Call Transcript ↗
MiNK Therapeutics (INKT) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
MiNK Therapeutics's Earnings Outlook ↗
 
Via Benzinga
News headline image
MiNK Therapeutics Extends Cash Runway ↗
Via The Motley Fool
News headline image
Earnings Scheduled For November 14, 2025 ↗
 
Via Benzinga
News headline image
MiNK INKT Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
MiNK Therapeutics Inc (NASDAQ:INKT) Reports Wider Q2 2025 Loss, Advances Clinical Pipeline Amid Market Caution ↗
MiNK Therapeutics Q2 2025 earnings miss EPS estimates with a $1.06 loss per share, but cash runway extends to mid-2026. Clinical progress in cancer and GvHD offers future potential. 
Via Chartmill
Topics Earnings
News headline image
MiNK Therapeutics Cuts Q2 Cash Use 31% ↗
Via The Motley Fool
News headline image
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Which stocks are moving on Tuesday? ↗
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.